Advertisement

Topics

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

15:31 EDT 17 May 2019 | Nature Publishing

Original Article: A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

NEXT ARTICLE

More From BioPortfolio on "A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment"

Advertisement
Quick Search
Advertisement
Advertisement